| European Case Law Identifier: | ECLI:EP:BA:2005:T121201.20050203 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 03 February 2005 | ||||||||
| Case number: | T 1212/01 | ||||||||
| Application number: | 94916236.6 | ||||||||
| IPC class: | A61K 31/505 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Pyrazolopyrimidinones for the treatment of impotence | ||||||||
| Applicant name: | Pfizer Limited, et al | ||||||||
| Opponent name: | VIVUS INC. ICOS Corp. SCHERING-PLOUGH CORPORATION Merck Patent GmbH Eli Lilly and Company Ortho-McNeil Pharmaceutical, Inc. MOCHIDA PHARMACEUTICAL CO. LTD. Sanofi-Aventis Bayer AG, Leverkusen Konzernverwaltung RP Patente Konzern EISAI Co., Ltd. Fujisawa Pharmaceutical Co., Ltd. Tanabe Seiyaku Co., Ltd. Bristol-Myers Squibb Company |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main and auxiliary requests 1 and 2 - added matter - yes Auxiliary requests 3 to 5 - inventive step - no Neither technical prejudice nor commercial success establishes inventive step |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t011212eu1.html
Date retrieved: 17 May 2021